Premium
Hims & Hers Health Inc (82W)
TG
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. David B. WellsLead Independent Director | 48,40k | 1,17M | Achat | 24,24 | 224,42k | 27,50% |
| 2026-05-18 | Mr. Oluyemi OkupeCFO | -7,95k | 148,09k | Derivative Exercise and Sale | 5,01 - 23,64 | 270,81k | - |
| 2026-04-20 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -9,46k | 283,89k | Automatic Disposition | 30,00 | 299,37k | -3,06% |
| 2026-04-20 | Mr. Oluyemi OkupeCFO | -7,09k | 212,49k | Automatic Disposition | 29,96 | 270,81k | -2,55% |
| 2026-04-20 | Mr. Oluyemi OkupeCFO | -12,55k | 267,59k | Derivative Exercise and Sale | 5,01 - 29,96 | 270,81k | - |
| 2026-04-16 | Mr. Oluyemi OkupeCFO | -48,74k | 1,29M | Automatic Disposition | 25,90 - 27,83 | 277,90k | -14,92% |
| 2026-04-17 | Mr. Oluyemi OkupeCFO | -6,18k | 141,15k | Derivative Exercise and Sale | 5,01 - 27,83 | 277,90k | - |
| 2026-04-09 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -422,93k | 0,00 | Other Disposition | - | 9,53M | -4,25% |
| 2026-04-06 | Mr. Oluyemi OkupeCFO | -3,98k | 59,49k | Derivative Exercise and Sale | 5,01 - 19,98 | 326,64k | - |
| 2026-03-20 | Mr. Oluyemi OkupeCFO | -4,49k | 84,20k | Derivative Exercise and Sale | 5,01 - 23,77 | 326,64k | - |
| 2026-03-20 | Mr. Oluyemi OkupeCFO | -4,73k | 112,37k | Automatic Disposition | 23,77 | 326,64k | -1,43% |
| 2026-03-17 | Mr. Mike ChiCOO | -97,29k | 2,40M | Automatic Disposition | 24,69 | 407,28k | -19,28% |
| 2026-03-17 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -4,81k | 118,81k | Automatic Disposition | 24,69 | 308,83k | -1,53% |
| 2026-03-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -5,53k | 136,51k | Automatic Disposition | 24,69 | 8,75k | -38,72% |
| 2026-03-13 | Mr. Mike ChiCOO | -198,54k | 4,92M | Sale to Issuer | 24,77 | 504,57k | -28,24% |
| 2026-03-13 | Mr. Mike ChiCOO | -39,21k | 971,33k | Derivative Exercise and Sale | 24,77 | 504,57k | - |
| 2026-03-13 | Mr. Mike ChiCOO | 32,89k | 0,00 | Derivative Exercise and Retained Stock | - | 504,57k | 6,97% |
| 2026-03-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -436,19k | 10,80M | Sale to Issuer | 24,77 | 9,53M | -4,38% |
| 2026-03-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90,30k | 2,24M | Derivative Exercise and Sale | 24,77 | 9,53M | - |
| 2026-03-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 74,07k | 0,00 | Derivative Exercise and Retained Stock | - | 9,53M | 0,78% |
| 2026-03-13 | Mr. Oluyemi OkupeCFO | -226,08k | 5,60M | Sale to Issuer | 24,77 | 331,37k | -40,56% |
| 2026-03-13 | Mr. Oluyemi OkupeCFO | -57,91k | 1,43M | Derivative Exercise and Sale | 24,77 | 331,37k | - |
| 2026-03-13 | Mr. Oluyemi OkupeCFO | 47,29k | 0,00 | Derivative Exercise and Retained Stock | - | 331,37k | 16,65% |
| 2026-03-13 | Ms. Christiane PendarvisIndependent Director | 15,21k | 0,00 | Derivative Exercise and Retained Stock | - | 51,77k | 41,60% |
| 2026-03-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 19,25k | 0,00 | Derivative Exercise and Retained Stock | - | 313,64k | 6,54% |
| 2026-03-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -22,17k | 549,23k | Derivative Exercise and Sale | 24,77 | 313,64k | - |
| 2026-03-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -146,58k | 3,63M | Sale to Issuer | 24,77 | 313,64k | -31,85% |
| 2026-03-13 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 12,16k | 0,00 | Derivative Exercise and Retained Stock | - | 14,28k | 571,73% |
| 2026-03-13 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -5,83k | 144,46k | Derivative Exercise and Sale | 24,77 | 14,28k | - |
| 2026-03-13 | Ms. Deborah M. AutorChief Policy Officer & Director | 21,61k | 0,00 | Derivative Exercise and Retained Stock | - | 27,78k | 349,91% |
| 2026-03-13 | Ms. Deborah M. AutorChief Policy Officer & Director | -11,31k | 280,20k | Derivative Exercise and Sale | 24,77 | 27,78k | - |
| 2026-03-13 | Dr. Patrick CarrollChief Medical Officer & Director | 12,50k | 0,00 | Derivative Exercise and Retained Stock | - | 182,44k | 7,36% |
| 2026-03-13 | Dr. Patrick CarrollChief Medical Officer & Director | -4,02k | 99,62k | Derivative Exercise and Sale | 24,77 | 182,44k | - |
| 2026-02-27 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -4,65k | 70,74k | Automatic Disposition | 15,21 | 167,18k | -2,71% |
| 2026-02-03 | Mr. Oluyemi OkupeCFO | -5,26k | 112,75k | Derivative Exercise and Sale | 5,01 - 26,44 | 99,47k | - |
| 2026-01-20 | Mr. Oluyemi OkupeCFO | -9,07k | 218,28k | Derivative Exercise and Sale | 5,01 - 30,34 | 99,47k | - |
| 2026-01-05 | Mr. Oluyemi OkupeCFO | -5,99k | 147,43k | Derivative Exercise and Sale | 5,01 - 33,79 | 99,47k | - |
| 2026-01-05 | Mr. Oluyemi OkupeCFO | -3,08k | 104,20k | Automatic Disposition | 33,79 | 99,47k | -3,01% |
| 2025-12-22 | Mr. Oluyemi OkupeCFO | -23,09k | 824,71k | Automatic Disposition | 35,72 | 102,19k | -18,43% |
| 2025-12-17 | Dr. Patrick CarrollChief Medical Officer & Director | -10,02k | 367,87k | Automatic Disposition | 36,71 | 169,94k | -5,57% |
| 2025-12-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8,41k | 308,77k | Automatic Disposition | 36,71 | 2,13k | -79,82% |
| 2025-12-17 | Ms. Deborah M. AutorChief Policy Officer & Director | -7,05k | 258,95k | Automatic Disposition | 36,71 | 6,18k | -53,32% |
| 2025-12-17 | Mr. Mike ChiCOO | -13,75k | 504,76k | Automatic Disposition | 36,71 | 305,16k | -4,31% |
| 2025-12-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 18,60k | 0,00 | Derivative Exercise and Retained Stock | - | 171,83k | 12,14% |
| 2025-12-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -22,82k | 827,12k | Derivative Exercise and Sale | 36,25 | 171,83k | - |
| 2025-12-15 | Dr. Patrick CarrollChief Medical Officer & Director | 10,02k | 0,00 | Derivative Exercise and Retained Stock | - | 179,96k | 5,90% |
| 2025-12-15 | Dr. Patrick CarrollChief Medical Officer & Director | -6,50k | 235,63k | Derivative Exercise and Sale | 36,25 | 179,96k | - |
| 2025-12-15 | Ms. Deborah M. AutorChief Policy Officer & Director | 7,05k | 0,00 | Derivative Exercise and Retained Stock | - | 13,23k | 114,23% |
| 2025-12-15 | Mr. Mike ChiCOO | 32,24k | 0,00 | Derivative Exercise and Retained Stock | - | 318,91k | 11,24% |
| 2025-12-15 | Mr. Mike ChiCOO | -39,87k | 1,45M | Derivative Exercise and Sale | 36,25 | 318,91k | - |
| 2025-12-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 9,12k | 0,00 | Derivative Exercise and Retained Stock | - | 10,54k | 643,09% |
| 2025-12-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8,87k | 321,43k | Derivative Exercise and Sale | 36,25 | 10,54k | - |
| 2025-12-15 | Mr. Oluyemi OkupeCFO | 47,19k | 0,00 | Derivative Exercise and Retained Stock | - | 125,28k | 60,44% |
| 2025-12-15 | Mr. Oluyemi OkupeCFO | -58,01k | 2,10M | Derivative Exercise and Sale | 36,25 | 125,28k | - |
| 2025-12-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 73,71k | 0,00 | Derivative Exercise and Retained Stock | - | 9,10M | 0,82% |
| 2025-12-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90,66k | 3,29M | Derivative Exercise and Sale | 36,25 | 9,10M | - |
| 2025-12-09 | Ms. Andrea G. Perez GarciaIndependent Director | -2,50k | 97,93k | Vente | 39,17 | 80,17k | -3,02% |
| 2025-11-28 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -1,08M | 0,00 | Other Disposition | - | 9,02M | -10,68% |
| 2025-12-01 | Mr. Mike ChiCOO | -5,00k | 0,00 | Other Disposition | - | 286,68k | -1,71% |
| 2025-11-24 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,63k | 92,66k | Automatic Disposition | 35,22 | 153,23k | -1,69% |
| 2025-11-17 | Mr. Oluyemi OkupeCFO | -23,19k | 687,67k | Derivative Exercise and Sale | 5,01 - 36,81 | 78,09k | - |
| 2025-11-10 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,64k | 112,15k | Automatic Disposition | 42,53 | 155,86k | -1,66% |
| 2025-11-07 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -3,53M | 0,00 | Other Disposition | - | 9,02M | -28,10% |
| 2025-10-27 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,64k | 132,11k | Automatic Disposition | 50,10 | 158,49k | -1,64% |
| 2025-10-17 | Mr. Oluyemi OkupeCFO | -11,59k | 579,32k | Derivative Exercise and Sale | 5,01 - 57,13 | 70,23k | - |
| 2025-10-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125,34k | 7,56M | Derivative Exercise and Sale | 2,43 - 63,49 | 9,28M | - |
| 2025-10-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50,33k | 3,16M | Automatic Disposition | 62,65 - 63,46 | 9,28M | -0,54% |
| 2025-10-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,64k | 143,40k | Automatic Disposition | 54,38 | 161,13k | -1,61% |
| 2025-10-10 | Mr. Mike ChiCOO | -900,00 | 46,29k | Derivative Exercise and Sale | 6,82 - 58,25 | 291,44k | - |
| 2025-10-03 | Mr. Oluyemi OkupeCFO | -11,60k | 586,31k | Derivative Exercise and Sale | 5,01 - 57,72 | 78,09k | - |
| 2025-10-01 | Mr. Mike ChiCOO | -250,00 | 11,12k | Derivative Exercise and Sale | 11,53 - 56,00 | 291,44k | - |
| 2025-09-29 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,64k | 155,03k | Automatic Disposition | 58,79 | 163,77k | -1,58% |
| 2025-09-29 | Mr. Oluyemi OkupeCFO | -49,83k | 2,75M | Derivative Exercise and Sale | 5,01 - 60,20 | 78,09k | - |
| 2025-09-29 | Mr. Oluyemi OkupeCFO | -35,17k | 2,12M | Automatic Disposition | 60,20 | 78,09k | -31,05% |
| 2025-09-24 | Mr. Mike ChiCOO | -2,10k | 108,17k | Derivative Exercise and Sale | 5,01 - 56,52 | 291,44k | - |
| 2025-03-07 | Mr. Mike ChiCOO | -5,70k | 0,00 | Other Disposition | - | 291,44k | -1,92% |
| 2025-09-22 | Mr. Oluyemi OkupeCFO | -23,58k | 1,36M | Automatic Disposition | 57,74 | 113,25k | -17,24% |
| 2025-09-17 | Mr. Mike ChiCOO | -13,75k | 694,32k | Automatic Disposition | 50,50 | 297,14k | -4,42% |
| 2025-09-17 | Dr. Patrick CarrollChief Medical Officer & Director | -10,02k | 506,06k | Automatic Disposition | 50,50 | 169,94k | -5,57% |
| 2025-09-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8,41k | 424,71k | Automatic Disposition | 50,50 | 1,42k | -85,57% |
| 2025-09-17 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,64k | 133,17k | Automatic Disposition | 50,50 | 166,40k | -1,56% |
| 2025-09-17 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -65,11k | 3,29M | Automatic Disposition | 50,57 | 9,33M | -0,69% |
| 2025-09-15 | Mr. Kare SchultzIndependent Director | 6,62k | 0,00 | Derivative Exercise and Retained Stock | - | 15,74k | 72,64% |
| 2025-09-15 | Mr. Mike ChiCOO | 72,11k | 0,00 | Derivative Exercise and Retained Stock | - | 310,89k | 30,20% |
| 2025-09-15 | Mr. Mike ChiCOO | -4,15k | 206,72k | Derivative Exercise and Sale | 5,01 - 56,00 | 310,89k | - |
| 2025-09-15 | Mr. Mike ChiCOO | -39,87k | 2,15M | Sale to Issuer | 53,96 | 310,89k | -11,37% |
| 2025-09-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 9,12k | 0,00 | Derivative Exercise and Retained Stock | - | 9,83k | 1 280,34% |
| 2025-09-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8,87k | 478,46k | Derivative Exercise and Sale | 53,96 | 9,83k | - |
| 2025-09-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 18,59k | 0,00 | Derivative Exercise and Retained Stock | - | 169,04k | 12,36% |
| 2025-09-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -22,83k | 1,23M | Derivative Exercise and Sale | 53,96 | 169,04k | - |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | 105,20k | 0,00 | Derivative Exercise and Retained Stock | - | 136,84k | 332,51% |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | -110,00k | 5,53M | Derivative Exercise and Sale | 5,01 - 55,25 | 136,84k | - |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | -35,00k | 1,95M | Automatic Disposition | 55,25 - 55,79 | 136,84k | -20,37% |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | -58,02k | 3,13M | Sale to Issuer | 53,96 | 136,84k | -29,78% |
| 2025-09-15 | Dr. Patrick CarrollChief Medical Officer & Director | 10,02k | 0,00 | Derivative Exercise and Retained Stock | - | 179,96k | 5,90% |
| 2025-09-15 | Dr. Patrick CarrollChief Medical Officer & Director | -6,50k | 350,74k | Derivative Exercise and Sale | 53,96 | 179,96k | - |
| 2025-09-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 164,37k | 0,00 | Derivative Exercise and Retained Stock | - | 9,40M | 1,78% |
| 2025-09-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90,67k | 4,89M | Sale to Issuer | 53,96 | 9,40M | -0,96% |
| 2025-09-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50,33k | 2,68M | Automatic Disposition | 52,90 - 54,21 | 9,40M | -0,53% |
| 2025-09-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125,34k | 6,40M | Derivative Exercise and Sale | 2,43 - 53,81 | 9,40M | - |
| 2025-08-26 | Mr. Oluyemi OkupeCFO | -11,58k | 447,95k | Derivative Exercise and Sale | 5,01 - 43,69 | 124,66k | - |
| 2025-08-25 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,57k | 114,49k | Vente | 44,53 | 150,45k | -1,68% |
| 2025-08-18 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125,34k | 5,34M | Derivative Exercise and Sale | 2,43 - 45,14 | 9,38M | - |
| 2025-08-18 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50,33k | 2,27M | Automatic Disposition | 44,97 - 45,05 | 9,38M | -0,53% |
| 2025-08-13 | Mr. Oluyemi OkupeCFO | -11,58k | 498,40k | Derivative Exercise and Sale | 5,01 - 48,05 | 124,66k | - |
| 2025-08-11 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,57k | 132,82k | Vente | 51,64 | 153,02k | -1,65% |
| 2025-08-07 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -660,00k | 33,38M | Vente | 50,58 | 9,43M | -6,54% |
| 2025-08-06 | Dr. Patrick CarrollChief Medical Officer & Director | -60,00k | 3,21M | Vente | 53,58 | 169,94k | -26,09% |
| 2025-07-31 | Mr. Mike ChiCOO | -26,60k | 1,59M | Derivative Exercise and Sale | 5,01 - 67,00 | 278,65k | - |
| 2025-07-28 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,57k | 150,98k | Automatic Disposition | 58,70 | 155,59k | -1,63% |
| 2025-07-23 | Mr. Mike ChiCOO | -15,85k | 808,12k | Derivative Exercise and Sale | 5,01 - 57,52 | 278,65k | - |
| 2025-07-21 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125,34k | 5,90M | Derivative Exercise and Sale | 2,43 - 49,60 | 10,09M | - |
| 2025-07-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50,33k | 2,53M | Automatic Disposition | 50,24 - 50,82 | 10,09M | -0,50% |
| 2025-07-14 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,57k | 122,99k | Automatic Disposition | 47,82 | 158,17k | -1,60% |
| 2025-07-14 | Mr. Oluyemi OkupeCFO | -7,59k | 323,89k | Derivative Exercise and Sale | 5,01 - 47,70 | 124,66k | - |
| 2025-07-14 | Mr. Oluyemi OkupeCFO | -3,99k | 190,52k | Automatic Disposition | 47,70 | 124,66k | -3,10% |
| 2025-07-07 | Mr. Oluyemi OkupeCFO | -6,44k | 268,17k | Derivative Exercise and Sale | 5,01 - 46,67 | 58,08k | - |
| 2025-07-07 | Mr. Oluyemi OkupeCFO | -5,14k | 240,08k | Automatic Disposition | 46,67 | 58,08k | -8,14% |
| 2025-06-30 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2,57k | 129,89k | Automatic Disposition | 50,50 | 160,74k | -1,57% |
| 2025-06-23 | Mr. Oluyemi OkupeCFO | -23,11k | 1,09M | Automatic Disposition | 47,25 | 133,80k | -14,73% |
| 2025-06-13 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 712,00 | 0,00 | Derivative Exercise and Retained Stock | - | 712,00 | - |
| 2025-06-13 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -17,27k | 994,48k | Derivative Exercise and Sale | 55,48 - 59,75 | 712,00 | - |
| 2025-06-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 10,12k | 0,00 | Derivative Exercise and Retained Stock | - | 163,31k | 6,60% |
| 2025-06-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -31,31k | 1,75M | Derivative Exercise and Sale | 55,48 - 59,75 | 163,31k | - |
| 2025-06-13 | Mr. Mike ChiCOO | 21,84k | 0,00 | Derivative Exercise and Retained Stock | - | 278,65k | 8,50% |
| 2025-06-13 | Mr. Mike ChiCOO | -65,27k | 3,69M | Derivative Exercise and Sale | 55,48 - 59,75 | 278,65k | - |
| 2025-06-13 | Mr. Oluyemi OkupeCFO | 47,18k | 0,00 | Derivative Exercise and Retained Stock | - | 156,90k | 42,99% |
| 2025-06-13 | Mr. Oluyemi OkupeCFO | -58,02k | 3,22M | Derivative Exercise and Sale | 55,48 | 156,90k | - |
| 2025-06-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 164,37k | 0,00 | Derivative Exercise and Retained Stock | - | 10,14M | 1,65% |
| 2025-06-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125,34k | 6,81M | Derivative Exercise and Sale | 2,43 - 58,61 | 10,14M | - |
| 2025-06-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -115,44k | 6,70M | Automatic Disposition | 56,35 - 59,45 | 10,14M | -1,13% |
| 2025-06-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90,67k | 5,03M | Sale to Issuer | 55,48 | 10,14M | -0,89% |
| 2025-06-10 | Mr. Mike ChiCOO | -5,40k | 270,97k | Derivative Exercise and Sale | 6,82 - 57,00 | 256,58k | - |
| 2025-06-12 | Dr. Delos M. CosgroveIndependent Director | 9,94k | 0,00 | Derivative Exercise and Retained Stock | - | 64,34k | 18,26% |
| 2025-06-12 | Ms. Anja Lucia ManuelIndependent Director | 19,98k | 0,00 | Derivative Exercise and Retained Stock | - | 24,98k | 399,50% |
| 2025-06-12 | Dr. Patrick CarrollChief Medical Officer & Director | 20,28k | 0,00 | Derivative Exercise and Retained Stock | - | 229,94k | 9,67% |
| 2025-06-13 | Dr. Patrick CarrollChief Medical Officer & Director | -6,18k | 342,70k | Derivative Exercise and Sale | 55,48 | 229,94k | - |
| 2025-06-12 | Ms. Deborah M. AutorChief Policy Officer & Director | 6,18k | 0,00 | Derivative Exercise and Retained Stock | - | 6,18k | - |
| 2025-06-12 | Mr. Christopher D. PayneIndependent Director | 19,98k | 0,00 | Derivative Exercise and Retained Stock | - | 129,98k | 18,16% |
| 2025-06-12 | Ms. Christiane PendarvisIndependent Director | 9,94k | 0,00 | Derivative Exercise and Retained Stock | - | 36,56k | 37,31% |
| 2025-06-12 | Mr. David B. WellsLead Independent Director | 9,94k | 0,00 | Derivative Exercise and Retained Stock | - | 176,02k | 5,98% |
| 2025-06-12 | Mr. Kare SchultzIndependent Director | 9,12k | 0,00 | Derivative Exercise and Retained Stock | - | 9,12k | - |
| 2025-06-12 | Ms. Andrea G. Perez GarciaIndependent Director | 9,94k | 0,00 | Derivative Exercise and Retained Stock | - | 82,67k | 13,66% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
